Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Sangart patents

List of Sangart patents

List of Benefit Cosmetics patents

List of Leviton (company) patents

List of Oasis Medical patents

List of companies in Austin Ventures's investment portfolio

List of companies in German Ventures's investment portfolio

Patents where

Current Assignee

Name

is

Sangart

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7622439 Method to enhance hemodynamic stability using oxygen carrying compositions	Patent 7622439 was granted and assigned to Sangart on November, 2009 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	7622439	November 24, 2009
	‌ US Patent 6974795 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin	Patent 6974795 was granted and assigned to Sangart on December, 2005 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	6974795	December 13, 2005
	‌ US Patent 7271145 Methods and compositions for oxygen transport comprising modified hemoglobin in plasma	Patent 7271145 was granted and assigned to Sangart on September, 2007 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	7271145	September 18, 2007
	‌ US Patent 8021858 Method for making polyalkylene oxide modified hemoglobin	Patent 8021858 was granted and assigned to Sangart on September, 2011 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	8021858	September 20, 2011
	‌ US Patent 8377868 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin	Patent 8377868 was granted and assigned to Sangart on February, 2013 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	8377868	February 19, 2013
	‌ US Patent 9493616 Methods for preparing PEG-hemoglobin conjugates using reduced reactant ratios	Patent 9493616 was granted and assigned to Sangart on November, 2016 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	9493616	November 15, 2016
	‌ US Patent 7625862 Method for making a high oxygen affinity modified hemoglobin for oxygen transport	Patent 7625862 was granted and assigned to Sangart on December, 2009 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	7625862	December 1, 2009
	‌ US Patent 8278275 Method to enhance hemodynamic stability using oxygen carrying compositions	Patent 8278275 was granted and assigned to Sangart on October, 2012 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	8278275	October 2, 2012
	‌ US Patent 7989414 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin	Patent 7989414 was granted and assigned to Sangart on August, 2011 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	7989414	August 2, 2011
	‌ US Patent 8609815 Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant	Patent 8609815 was granted and assigned to Sangart on December, 2013 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	8609815	December 17, 2013
	‌ US Patent 6844317 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin	Patent 6844317 was granted and assigned to Sangart on January, 2005 by the United States Patent and Trademark Office.		Sangart		United States Patent and Trademark Office	6844317	January 18, 2005

11 results

0 selected

11 results

0 selected